• In adults in the Western world, cardiac valve lesions are usually caused by degenerative heart disease, which produces aortic valve stenosis and insuffi ciency and mitral insuffi ciency.
• In developing countries, rheumatic heart disease is the most frequent cause of valve lesions, including stenosis, insuffi ciency, or both. It is the leading cause of mitral stenosis.
• A common cause of aortic stenosis is a congenitally bicuspid aortic valve that calcifi es later in life.
• Myocardial ischemia, as well as nonischemic cardiomyopathy, can alter mitral valve geometry and result in severe mitral regurgitation. • Treatment should be considered for any patient with symptoms of heart valve disease.
• Asymptomatic patients with critical aortic stenosis should be referred for surgical intervention. In these cases, the onset of symptoms (chest pain, congestive heart failure, and syncope) is associated with poor survival without surgery.
• Asymptomatic patients with aortic insuffi ciency should be referred for surgery on the basis of enlarged left ventricular size on echocardiography.
• In adults, symptomatic aortic valve disease almost always necessitates valve replacement.
• Stenotic mitral valves can often be repaired by interventional cardiologists, using a double-balloon valvotomy technique.
• Balloon valvotomy has fallen into disfavor for repairing stenotic aortic valves, because the results are not long lasting.
• When mitral valve surgery is necessary, repair is preferred over valve replacement.
• If the anterior leafl et is relatively normal, most mitral lesions can be repaired by means of a combined commissurotomy, posterior leafl et resection, and annuloplasty. When deterioration is advanced, valve replacement is often unavoidable.
• Recent techniques using artifi cial chordae tendineae have expanded the indications for mitral valve repair.
• Tricuspid valve disease can be alleviated by an annuloplasty, a valvotomy, both of these procedures, or valve replacement. Functional tricuspid insuffi ciency accompanying mitral stenosis will sometimes resolve after correction of the mitral condition.
• Postoperatively, the main complication of valve replacement is thromboembolism, which is associated mostly with mechanical prostheses, especially in the mitral position. Patients with mitral mechanical prostheses should routinely take an anticoagulant such as sodium warfarin. In addition, those with aortic mechanical prostheses should undergo long-term anticoagulation. Most patients with chronic atrial fi brillation should also receive warfarin.
• For redo valve procedures, the operative mortality is increased, particularly in patients with poor cardiac functional status and a need for emergency surgery.
• Limited-access heart valve surgery, with the use of a small incision, is gaining popularity. It may be performed via the port access approach, which entails peripheral perfusion and use of a balloon catheter for aortic occlusion; with standard cannulation and a specially designed aortic cross-clamp; or with a combination of these two approaches. The results are similar to those obtained in conventional procedures using a sternotomy, but some patients report less musculoskeletal discomfort after the limited-access procedure. by most surgeons until World War II, when Harken 1 successfully removed foreign bodies from the heart. Once surgeons realized that the heart could be operated on successfully, attention turned toward correcting congenital defects, including valve stenosis and insuffi ciency, and modern valve surgery began to evolve. In the late 1940s, Harken et al., 2 Bailey, 3 and Brock's group 4 reported the successful repair of mitral valve disease. Not until the development of cardiopulmonary bypass and open-heart surgery in the 1950s, however, were surgeons able to attack acquired valve disease. By the end of that decade, the caged-ball valve design, pioneered by Harken, Starr, and Edwards, made valve replacement possible. The ensuing decades have seen a continual advancement in valve prostheses and repair techniques. More than 300,000 patients worldwide were expected to undergo heart valve surgery in 2004. 5 Of the 2,500 open-heart operations performed each year at the Texas Heart Institute in Houston, Texas, about 20% involve the repair of valve lesions. This chapter describes our standard surgical approaches for treating acquired valvular heart disease.
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General Considerations
Whereas the aortic and mitral valves may be diseased either alone or in combination, the tricuspid valve is rarely subject to isolated disease, except when affected by endocarditis, as often seen in intravenous drug abusers.
Today, diseased stenotic valves can often be repaired nonsurgically by interventional cardiologists, using a doubleballoon valvotomy technique. Although highly successful for repairing the stenotic mitral valve, this approach is less useful for aortic valve repair, because its benefi ts are not long lasting; after the procedure, many patients have a decreased gradient across the aortic valve, but this effect has been reported to last for only a short time. [14] [15] [16] [17] Complications of balloon mitral valvuloplasty include regurgitation, annular rupture, and an atrial septal defect.
When valve surgery becomes necessary, the indications should be based on symptoms, as well as physiologic and pathologic fi ndings, and the risk-benefi t ratio should be carefully examined in each case. Unfortunately, few evidencebased guidelines are available to facilitate surgical decision making in valvular heart disease.
The optimal surgical approach depends on the degree of physiologic disturbance, the extent and nature of the pathologic changes, and the expertise of the surgeon. Whenever possible, we perform valve repair rather than replacement. Repair has a number of advantages, eliminating not only the need for lifelong anticoagulation but also the threat of mechanical dysfunction and paravalvular leakage. Transesophageal echocardiography is becoming widely used intraoperatively for assessing the valve anatomy before repair and for determining the adequacy of repair at the end of the procedure.
Since the advent of valve replacement surgery, much experience has been gained with both mechanical and bioprosthetic valves. Either type of valve has benefi ts and drawbacks. Early mechanical valves were vulnerable to mechanical failure, but today's models are quite durable, especially when made with pyrolytic carbon (Fig. 24.1 ). When valve replacement is unavoidable, we prefer bileafl et mechanical prostheses in our younger patients. These valves are reliable and have a low profi le, excellent hemodynamic qualities, and an extremely low incidence of complications, including thromboembolism.
Bioprostheses are less durable than mechanical valves and are vulnerable to structural deterioration and calcifi cation, which occurs mainly in adolescent patients. The newer generation of bioprosthetic valves offers longer operative-free survival than previous models, especially in the aortic position ( Fig. 24.2) . As a result, the age of patients considered candidates for these valves has been gradually lowered. Today, to avoid the need for anticoagulants, many younger patients opt for a bioprosthesis and accept the risk of requiring a reoperation at some later date. After trying various methods of suturing valve prostheses, some surgeons at our institution have reverted to using a continuous monofi lament polypropylene suture in some cases. 12 This simple technique expedites implantation in any valve position and provides even more security than do individual mattress sutures. The continuous-suture technique also eliminates the need for porous felt pledgets, which can become a source of infection.
To prevent infective endocarditis, we routinely administer bactericidal antibiotics to all patients undergoing prosthetic valve replacement. Antibiotics are given before surgery and are continued until all catheters are removed.
The valve is approached through a standard median sternotomy. After heparin (3 mg/kg) has been administered, access to the systemic arterial system is gained by cannulating the ascending aorta. Cannulation for venous outfl ow depends on which valve is involved. For aortic valve procedures, we position the tip of a single right atrial cannula in the orifi ce of the inferior vena cava so that some of the perforations are in the right atrium. For single or combined procedures involving the mitral valve, the venae cavae are often cannulated separately.
In patients undergoing valve replacement, we routinely use moderate systemic hypothermia and cardiac hypothermia as well as a membrane oxygenator. Patients with severe left ventricular hypertrophy may benefi t from the addition of propranolol to the cardioplegic solution (approximately 1 mg for a normal adult). In such patients, retrograde coronary sinus blood cardioplegia may also be useful for myocardial protection. Our cardiopulmonary bypass time rarely exceeds 1 hour.
In combined mitral and aortic procedures, the mitral valve is treated fi rst. Traditionally, double valve replacement necessitates two separate incisions to visualize the valve apparatus. When this approach is impractical, as in patients who have undergone a previous median sternotomy, the mitral valve can be replaced through the aortic root after the aortic valve has been excised. 7 
Mitral Valve
The mitral valve may be affected by stenosis, insuffi ciency, or both. The type of surgical treatment depends on the operative fi ndings. Many mitral lesions can be repaired by means of a commissurotomy, posterior leafl et resection, and annuloplasty. When deterioration is advanced, however, valve replacement may be unavoidable.
Mitral Stenosis
Indications for Surgery
Surgery should be considered for any patient with symptomatic mitral stenosis, including persons in New York Heart Association (NYHA) class III or IV who have atrial fi brillation, increasing pulmonary hypertension, systemic embolization, or infective endocarditis. In addition, class II patients should be considered for surgery if they are older than 40 years, have a signifi cantly reduced valve area, or have valverelated lifestyle limitations.
Mitral Repair Techniques
The time-honored method for alleviating "pure" mitral stenosis with minimal or no calcifi cation is a commissurotomy with subvalvular dissection of fi brosed chordae tendineae and papillary muscles. Usually, the valve is fused at both commissures and has a slit-like opening. Freeing the fused commissures produces a functional, near-normal valve.
Although a closed commissurotomy is possible with the aid of a transventricular dilator, we always perform an open procedure with cardiopulmonary bypass support. This approach enables us not only to assess the extent of disease and determine the best operative strategy but also to perform an anatomic repair. Moreover, the open approach facilitates accurate division of the commissure and allows left atrial thrombi to be extracted.
Mitral Valve Replacement
For patients with extensive calcifi cation or severe fi brotic distortion, especially in the subvalvular area, valve replacement is the only option.
Recently, it has become clear that, to ensure maximal postoperative ventricular function, the chordal attachments to papillary muscles should be preserved. [18] [19] [20] Therefore, insofar as possible, we remove only the anterior mitral leafl et, sparing the posterior leafl et and the chordal attachments.
In excising the mitral valve, the surgeon must take care not to damage the posterior annulus, which can rupture if an oversized valve is inserted or excessive tissue removed. (This uncommon complication is most frequently seen in patients with severe annular calcifi cation and is associated with a high operative mortality.) Furthermore, the nearby circumfl ex coronary artery may be injured if sutures are placed too deeply during valve replacement or annuloplasty.
The valve is usually approached through a standard left atrial incision. If the case is complex, however, or if the patient has undergone previous mitral surgery, a transseptal route may be more appropriate. For combined mitral-aortic procedures, a single transverse aortotomy can be used, as described above.
Mitral Insuffi ciency
Indications for Surgery
Close follow-up observation is essential for patients with mitral insuffi ciency. If regurgitation is mild (1 to 2+), surgery may be postponed indefi nitely. However, operation should be considered for patients with moderately severe or severe (3 to 4+) regurgitation or for any patient with atrial fi brillation, increasing pulmonary hypertension, or disabling symptoms. For those with infective endocarditis, surgery can be performed electively if antibiotic therapy is successful; otherwise, emergency valve replacement is usually necessary.
According to Haan and colleagues, 21 the following variables are associated with a heightened operative risk: age >75 years, renal failure, and the need for an emergent or a salvage procedure. These researchers found that for most patients with ventricular dysfunction, mitral valve surgery did not entail a prohibitive operative risk. In fact, mortality rates remained fairly constant regardless of the ejection fraction for low-risk to medium-risk patients, increasing only in the high-risk category (predicted risk >10%). Various recent mitral valve surgery series involving patients with an ejection fraction of <20% have had an operative mortality of <2%. 22, 23 In this respect, clinical experience is at variance with the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines, 24 which state that valve replacement for mitral insuffi ciency should be performed only in patients who have an ejection fraction of at least 30%.
Mitral Valve Repair
In many series, repair is appropriate for incompetent nonrheumatic mitral valves in more than 90% of the cases. As long as the anterior leafl et is functional, there are no absolute contraindications to reconstruction. 25 Compared with valve replacement, repair is associated with improved left ventricular function and better long-term survival. A variety of reconstructive techniques have been described. 18, [26] [27] [28] [29] [30] Although we still occasionally perform annuloplasty by means of commissural plication, we prefer to insert an annuloplasty ring or a posterior annuloplasty band (Fig. 24.3 ). Both of these methods reduce the annular circumference without necessitating the placement of restrictive sutures in either the anterior leafl et or the anterior portion of the annulus.
We also use an annuloplasty ring to treat mitral incompetence secondary to valve prolapse. Depending on the surgeon's preference, a Carpentier, Cooley, Duran, or PuigMassana-Shiley ring 11 or a Cosgrove band can be used. The device reduces the overall circumference of the annulus, eliminating prolapse of the posterior leafl et. We occasionally use a cut section of a 22-mm Dacron graft. This ring is simple and inexpensive to produce.
In patients with ischemic mitral regurgitation, the valve structure tends to be normal. When these patients have annular dilatation or ruptured chordae tendineae on the posterior leafl et without calcifi cation or leafl et fi brosis, an annuloplasty and leafl et repair or resection are usually satisfactory. To decrease the overall annular circumference, we again insert an annuloplasty ring, thereby making the best use of available valve tissue and rendering the valve competent. Even for combined coronary-valvular procedures, our mean ischemic time is 55 minutes. If chordae tendineae are ruptured, they should be removed; the leafl et is then either excised or imbricated. When chordal or papillary rupture affects the anterior leafl et, artifi cial chordae may be fashioned from a polytetrafl uoroethylene suture. In our experience, however, the valve has often needed to be replaced.
For mitral incompetence associated with a ventricular aneurysm, we perform an endoaneurysmorrhaphy 10 by inserting an oval patch graft inside the left ventricle to restore the ventricular anatomy. Once the papillary muscles have returned to their normal position, mitral regurgitation is often alleviated.
In 1991, Alfi eri introduced the "edge-to-edge" technique 31 for repairing mitral valves that are insuffi cient because of a prolapsed anterior leafl et. Later, this technique was applied to other conditions involving mitral insuffi ciency. When performed with a septal myectomy, the edge-to-edge technique addresses both causes of dynamic obstruction in hypertrophic cardiomyopathy. By sparing the natural valve and submitral apparatus, this approach preserves ventricular function.
For patients with advanced congestive heart failure, open surgery may entail a prohibitive risk. New catheter-based technology has recently been developed to address mitral regurgitation by means of a percutaneous approach, which may allow these patients to undergo mitral repair without stopping the heart or opening the chest. One such device facilitates placement of a clip that attaches the free edges of the anterior and posterior leafl ets, effecting an edge-to-edge repair (Evalve, Redwood City, CA). In other investigational approaches (Viacor, Inc., Wilmington, MA), the operator works through the coronary sinus to geometrically manipulate the posterior annulus and thereby improve coaptation of the leafl et edges (Fig. 24.4 ). Although these methods are still undergoing development, early clinical experience is promising. 
Mitral Valve Replacement
In advanced rheumatic heart disease with foreshortening and thickening of the mitral leafl ets and in instances of subacute bacterial endocarditis, valve replacement (see above) is the only available option.
Intravalvular Implantation
In patients with sound, fl exible mitral leafl ets and supple chordae, we sometimes use a technique known as in situ intravalvular implantation, particularly if the annular tissue is of poor quality. 9 To prevent obstruction of the valve prosthesis, we divide the anterior leafl et and insert it into the annulus. We then implant a low-profi le prosthesis, affi xing it to the valve leafl et and annulus with continuous sutures.
In this manner, we are able to spare both the anterior and posterior chordal and papillary mechanisms.
Aortic Valve
Although congenital aortic valve disease in children is often amenable to repair, the same cannot be said for acquired aortic valve disease. Therefore, in adults, operations for incompetent or stenotic aortic valves almost always entail valve replacement. Some surgeons believe that the currently recommended age threshold (≥65 years) for implanting a bioprosthesis in the aortic position could be lowered further. 32 A good outcome depends on optimal surgical timing, but this can be hard to judge, especially in asymptomatic patients with severe disease and symptomatic patients with highly advanced disease.
Indications for Surgery
The primary indication for aortic valve surgery is the presence of symptoms (angina, syncope, or dyspnea on exertion). As long as patients are asymptomatic, their prognosis remains good, even if the stenosis itself is severe. However, the ACC/ AHA recommends valve replacement for patients with left ventricular systolic dysfunction, as characterized by a subnormal resting ejection fraction (documented by two consecutive measurements or independent tests). Even if the ejection fraction is normal, valve replacement should be considered for patients with an end-diastolic dimension of >75 mm or an end-systolic dimension of >55 mm. In small patients of either sex, these threshold values may need to be reduced appropriately.
Once symptoms develop, aortic valve replacement should be undertaken. Patients with congestive heart failure related to aortic stenosis have a 50% chance of dying within 2 years after the onset of symptoms. Similarly, patients who present with syncope or angina have a 50% chance of dying within 3 and 5 years, respectively. A fairly objective indicator is the pressure fl ow gradient across the left ventricular outfl ow tract. When this gradient is >50 mm Hg, operative correction is generally indicated. According to Carabello, 33 however, patients with a low aortic valve gradient and low ejection fraction without inotropic reserve will probably not benefi t from valve replacement.
Valve-Sparing Aortic Root Surgery
When the aortic valve is affected by an aneurysm of the aortic root, the entire root and valve are traditionally replaced with a composite valved graft. Recently, however, we began using a new valve-sparing technique whenever possible (Fig.  24.5 ). Once the entire aneurysmal segment, including the sinuses of Valsalva, has been removed, the aorta is reconstructed with a Dacron graft. The native valve is then incorporated into the inner wall of the graft. This technique is suitable for patients whose aortic valve is structurally normal and not calcifi ed, torn, or infected (see also Percutaneous Valve Replacement, below). 
Tricuspid Valve
Acquired lesions of the tricuspid valve may be either primary or secondary. In managing tricuspid disease, the surgeon must weigh each case carefully and select the treatment plan that offers the best chance of long-term success. Surgery is generally required for concomitant tricuspid and mitral valve disease with pulmonary hypertension and right ventricular failure. However, functional tricuspid insuffi ciency, which sometimes accompanies mitral stenosis, often resolves after correction of the mitral condition.
When tricuspid insuffi ciency accompanies disease of the mitral or aortic valve or both, the prognosis is unfavorable. According to Bernal and colleagues, 34 predictors of hospital mortality are renal insuffi ciency, prolonged cardiopulmonary bypass, use of a biologic prosthesis, and use of inotropic drugs; predictors of late mortality are age >60 years, left ventricular ejection fraction <50%, and NYHA functional class IV status.
Primary Lesions
Primary tricuspid lesions include rheumatic valvulitis, bacterial endocarditis, carcinoid valvulopathy, and traumatic rupture. Stenosis or regurgitation caused by rheumatic valvulitis can be alleviated by an annuloplasty, a valvotomy, or a combination of these procedures. Alternatively, valve replacement can be performed. When bacterial endocarditis results in advanced tricuspid valve destruction, as it frequently does in drug addicts, the surgeon is advised to perform a total valvectomy rather than implant a foreign body or an artifi cial valve. 35 If patients survive, they may then undergo elective valve replacement once the infectious process has resolved.
Tricuspid valve disease secondary to chronic placement of transvalvular pacing leads and defi brillator coils is being seen with increasing frequency. When surgical correction is required, the leads must be removed and replaced with epicardial ones if indicated.
Traumatic disruption of the tricuspid valve can result from a closed, crushing chest injury. We have treated several automobile accident victims with papillary muscle disruption. Such cases always necessitate valve replacement or repair. 36, 37 Secondary Lesions Secondary tricuspid lesions tend to be more common than primary ones. Secondary lesions arise when rheumatic valvulitis in the mitral (and perhaps also the aortic) position results in pulmonary hypertension and increased pulmonary vascular resistance, thereby straining the right ventricle and causing pulmonary and tricuspid valve insuffi ciency by secondary annular dilatation. Treatment of secondary lesions requires sound surgical judgment and expertise. If the leaflets are relatively normal, repair can be achieved by decreasing the overall circumference of the tricuspid annulus. However, if the leafl ets are calcifi ed or eroded because of infection or ruptured chordae tendineae, valve replacement may be necessary.
Postoperative Care
Most patients who undergo valve replacement receive temporary pacing electrodes to prevent heart block or other arrhythmias during the early postoperative period. The pacing wires are usually removed after 4 or 5 days. A mediastinal chest tube is left in place for 48 hours.
Optimal postoperative care depends on familiarity with the potential complications of valve surgery. The most feared threat is thromboembolism, which is mainly associated with mechanical prostheses. Patients with these devices in the mitral position should routinely take an anticoagulant such as sodium warfarin (Coumadin). Those with aortic prosthe- Infection is a relatively rare complication of prosthetic valve implantation. In patients with valve prostheses, we routinely continue postoperative bactericidal antibiotic therapy until all invasive catheters have been removed. Subsequently, these patients should receive prophylactic antibiotics whenever they undergo dental procedures or operations on the lower genitourinary or gastrointestinal tract.
When bacterial endocarditis is diagnosed, a second operation may be necessary to replace the prosthetic valve. Although we begin antibiotic therapy to sterilize the bloodstream before surgery, we do not wait when valve replacement is needed, because we have found valve replacement to be successful even in the presence of active infection. Moreover, delay can be dangerous if it results in irreversible hemodynamic deterioration or ongoing destruction of periprosthetic structures.
Valve dehiscence may occasionally result from infection, technical errors, or tissue failure. This complication can be alleviated by a repeat open cardiac procedure in which additional sutures are inserted to secure the valve.
Today's mechanical prostheses are extremely durable, and valve fracture or failure is quite uncommon. When such problems do arise, a repeat operation is mandatory.
Redo Valve Procedures
Redo valve procedures can present technical challenges, including dissection of adhesions from previous surgery. The operative mortality may be two or three times higher than for initial valve operations, 38 particularly in patients with poor NYHA functional status and a need for emergency surgery. For this reason, reoperation should be undertaken before cardiac functional status deteriorates and other organs are adversely affected.
In patients with tissue valves, the following factors do not signifi cantly increase the mortality of redo surgery: age at surgery, previous coronary artery bypass grafting (CABG), position of the valve replaced, type of implant, and the presence of coronary artery disease. 39 Therefore, lowering the age range for tissue valve implantation may be justifi ed.
In selected patients, limited-access valve surgery can achieve results comparable to those of traditional operations while hastening recovery.
Limited-Access Valve Surgery
A number of techniques have been introduced for performing limited-access valve surgery. These nonsternotomy approaches reduce the trauma of access and minimize the need for cardiac dissection for all types of valve repair and replacement. Because limited-access valve surgery avoids a full median sternotomy, it is especially suited for patients at high risk for sternal infection or redo procedures. A number of incisions and techniques have been described for mitral and aortic valve surgery. One technique, popularized by Gundry 40 utilizes a mini-sternotomy that extends from the sternal notch to the second or third interspace. A ministernotomy can be performed through a 7-or 8-cm skin incision and avoids division of the lower sternum, the site most frequently involved in postoperative complications. This approach is suited for both aortic and mitral valve procedures. Another option is a right mini-thoracotomy, as popularized by Cosgrove, 41 which is excellent for mitral valve procedures.
Some variations of these and other limited-access incisions involve a port access approach, which entails peripheral perfusion and use of a balloon catheter for aortic occlusion. 42 Other approaches use a modifi ed incision but standard central cannulation and a modifi ed aortic cross-clamp. One of the main challenges of this approach is to keep the cardiopulmonary bypass time within an acceptable range. In a few centers, limited-access valve surgery is performed with the aid of endoscopic visualization and robotic surgical systems. This approach has the potential to reduce further the size of the surgical incision.
Limited-access aortic valve replacement with the aid of high thoracic epidural anesthesia in a conscious patient has been reported. 43 This approach avoids the potential morbidity related to general anesthesia and endotracheal intubation.
Many surgeons are reluctant to adopt limited-access valve surgery, but this approach has been so widely publicized that patients often request it. Though a reasonable approach for most patients with single-valve disease, it is not well suited for obese patients or those with complex valve procedures, multivalve disease, or severe atherosclerosis prohibiting peripheral cannulation.
Percutaneous Valve Replacement
For many elderly or debilitated patients with multiple comorbidities, conventional valve replacement may pose a significant risk. Percutaneous valve replacement is an attractive nonsurgical alternative that is currently being developed and that offers numerous potential benefi ts. In 2002, Cribier and coworkers 44 successfully implanted an aortic valve percutaneously using the antegrade approach, passing the collapsible valve up the femoral vein, across the atrial septum and mitral valve to reach the aortic annulus. More recently, Paniagua and colleagues, 45 at our hospital, performed a similar procedure using a collapsible prosthesis that needs no supportive struts; these researchers used the retrograde approach, which has several advantages over the antegrade one. This technology is associated with numerous challenges, but early clinical work shows promise. If the technical hurdles can be surmounted, percutaneous aortic valve replacement may prove to be an important advance in the treatment of valve disease.
Outcomes
Heart valve surgery can be performed safely and effectively, restoring countless patients to normal, healthy lives. The Cleveland Clinic, 46 which performs the largest number of valve procedures in the United States, reported a 2.9% overall mortality for the 2,254 valve operations that it performed in 2003. Valve replacement generally entails a higher morbidity and mortality than most other routine heart operations, 47 and its outcome often depends more on patient risk factors than on valve choice or technical considerations. After aortic and mitral valve replacement, respectively, the 10-and 15-year mortality is as high as 20%. 48 
Isolated Versus Combined Operations
Mitral Position
As of late 2004, the National Cardiac Database maintained by the Society of Thoracic Surgeons 49 reported an unadjusted operative mortality of approximately 2% for mitral valve repair alone, 7.5% for mitral repair plus CABG, 6.4% for mitral replacement alone, and 11% for mitral replacement plus CABG.
Aortic Position
In the National Cardiac Database, the unadjusted operative mortality was approximately 4.6% for aortic valve replacement alone, 6.2% for aortic valve replacement plus CABG, and 10% for combined aortic and mitral valve replacement in late 2004.
Mechanical Versus Bioprosthetic Valves
Mitral Position
The Department of Veterans Affairs randomized trial 50 showed that, 15 years after mitral valve replacement, allcause mortality was no different with mechanical valves than with bioprosthetic ones. Although the bioprostheses had more structural deterioration in all age groups, this complication was more prevalent in younger patients (<65 years old). Both valve types had similar thromboembolism rates, but mechanical valves tended to cause more bleeding complications. Similarly, the Edinburgh randomized trial, 51 which followed patients for 20 years, showed that both types of valves yielded similar mortality and thromboembolism rates but that mechanical valves resulted in increased bleeding.
Aortic Position
At 18 years' follow-up, Veterans Affairs patients with an aortic mechanical valve had lower mortality and reoperation rates than those with an aortic bioprosthesis. 51 This difference was fi rst noticed at 10 years. Primary valve failure occurred more frequently after mitral valve replacement (MVR) and in patients younger than 65 years; this complication arose 5 to 6 years postoperatively in MVR patients and 7 to 8 years postoperatively in aortic valve replacement (AVR) patients. As in the mitral position, bleeding was more common in the patients with mechanical valves, and other complications were similar with both valve types.
Limited-Access Versus Conventional Valve Surgery
Mitral Position
In one of the largest single-center studies to compare the outcomes of limited-access versus conventional valve procedures, Mihaljevic and coworkers 52 documented a perioperative mortality of 0.2% for limited-access mitral procedures and 0.3% for conventional mitral procedures. At 1, 3, and 5 years, the actuarial survival rates were 98%, 97%, and 95% versus 97%, 91%, and 86% after these two types of surgery, respectively.
Aortic Position
The same study showed a perioperative mortality of 2% for limited-access aortic valve surgery versus 2.7% for conventional aortic valve surgery. At 1, 3, and 5 years, the two respective approaches yielded actuarial survival rates of 98%, 94%, and 82% versus 94%, 90%, and 86%.
Summary
Introduced in the mid-20th century, valve repair and replacement continue to account for a large share of the cardiac surgeon's caseload. Treatment should be considered for any patient with symptoms. Stenotic mitral valves can often be repaired by an interventional cardiologist using a doubleballoon valvotomy technique, but this approach should be avoided for aortic valve repair, as it does not offer longlasting results. When surgery is necessary, repair (if possible) is preferred over valve replacement. If replacement is unavoidable, surgeons can choose from a wide array of prosthetic valves and operative techniques, including limited-access approaches. Postoperatively, the most dreaded complication is thromboembolism. To prevent this problem, patients with mitral mechanical prostheses should routinely take an anticoagulant such as sodium warfarin; those with aortic mechanical prostheses should also undergo long-term anticoagulation. When repeat valve surgery is necessary, it should be undertaken before cardiac functional status deteriorates and other organs are adversely affected. Catheterbased approaches for valve repair are currently being developed, but their merit is not yet clear. Nevertheless, the currently available options are offering even high-risk surgical patients a chance to overcome their valve disease and enjoy a normal life.
